Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qianjun Chen

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Frontiers in Oncology|June 28, 2021
Acupuncture for Breast Cancer: A Systematic Review and Meta-Analysis of Patient-Reported OutcomesYuzhu Zhang, Yang Sun, Dongmei Li, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2023
Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study)Jiayu Wang, Li Cai, Yanqiu Song, et al.
JMIR Public Health and Surveillance|December 7, 2023
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in ChinaShaohua Zhang, Jianbin Li, Ruonan Xu, et al.
Cancer Research|March 20, 2024
A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast CancerMengmeng Zhang, Kaiwen Zhou, Zilin Wang, et al.
Molecular & Cellular Proteomics : MCP|March 2, 2025
Proteomic Analysis of Human Follicular Fluid-Derived Exosomes Reveals That Insufficient Folliculogenesis in Aging Women is Associated With InfertilityZhen Liu, Qilin Zhou, Jun Zan, et al.
Cell Reports. Medicine|April 24, 2026
Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancerMeiheng Sun, Hang Luo, Shuangying Qiao, et al.
Acta Pharmaceutica Sinica. B|May 30, 2023
Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trialBinghe Xu, Qingyuan Zhang, Xichun Hu, et al.
Eclinicalmedicine|September 29, 2020
Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020Jianbin Li, Haibo Wang, Cuizhi Geng, et al.
Nature Communications|April 8, 2025
Spatially resolved atlas of breast cancer uncovers intercellular machinery of venular niche governing lymphocyte extravasationXin Wang, Zhanyu Wang, Qijun Liao, et al.
Signal Transduction and Targeted Therapy|May 21, 2026
Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trialWenjing Wu, Yaping Yang, Haizhu Chen, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|June 28, 2021
Acupuncture for Breast Cancer: A Systematic Review and Meta-Analysis of Patient-Reported OutcomesYuzhu Zhang, Yang Sun, Dongmei Li, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2023
Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study)Jiayu Wang, Li Cai, Yanqiu Song, et al.
JMIR Public Health and Surveillance|December 7, 2023
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in ChinaShaohua Zhang, Jianbin Li, Ruonan Xu, et al.
Cancer Research|March 20, 2024
A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast CancerMengmeng Zhang, Kaiwen Zhou, Zilin Wang, et al.
Molecular & Cellular Proteomics : MCP|March 2, 2025
Proteomic Analysis of Human Follicular Fluid-Derived Exosomes Reveals That Insufficient Folliculogenesis in Aging Women is Associated With InfertilityZhen Liu, Qilin Zhou, Jun Zan, et al.
Cell Reports. Medicine|April 24, 2026
Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancerMeiheng Sun, Hang Luo, Shuangying Qiao, et al.
Acta Pharmaceutica Sinica. B|May 30, 2023
Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trialBinghe Xu, Qingyuan Zhang, Xichun Hu, et al.
Eclinicalmedicine|September 29, 2020
Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020Jianbin Li, Haibo Wang, Cuizhi Geng, et al.
Nature Communications|April 8, 2025
Spatially resolved atlas of breast cancer uncovers intercellular machinery of venular niche governing lymphocyte extravasationXin Wang, Zhanyu Wang, Qijun Liao, et al.
Signal Transduction and Targeted Therapy|May 21, 2026
Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trialWenjing Wu, Yaping Yang, Haizhu Chen, et al.
Pageof 8